TerminatedPhase 1NCT02683148
DHEA in Synovial Sarcoma Patients
Studying Synovial sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Brian A Van Tine, M.D., Ph.D.Washington University School of Medicine
- Intervention
- DHEA(drug)
- Enrollment
- 11 target
- Eligibility
- 16 years · All sexes
- Timeline
- 2016 – 2019
Study locations (1)
- Washington University School of Medicine, St Louis, Missouri, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02683148 on ClinicalTrials.govOther trials for Synovial sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07174427Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial SarcomaTakara Bio Inc.
- RECRUITINGPHASE1NCT06946225ACTengine® IMA203 Combined With mRNA-4203Immatics US, Inc.
- RECRUITINGNCT05910307Synovial Sarcoma Registry / Biospecimen RepositoryChildren's Hospital of Philadelphia